Heron Therapeutics (HRTX) Short Interest Ratio & Short Volume $1.19 -0.05 (-4.03%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Heron Therapeutics Short Interest DataHeron Therapeutics (HRTX) has a short interest of 28.81 million shares. This marks a -5.97% decrease in short interest from the previous month. The short interest ratio (days to cover) is 15.7, indicating that it would take 15.7 days of the average trading volume of 2.42 million shares to cover all short positions.Current Short Interest28,810,000 sharesPrevious Short Interest30,640,000 sharesChange Vs. Previous Month-5.97%Dollar Volume Sold Short$50.13 millionShort Interest Ratio15.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares152,095,000 sharesPercentage of Shares Shorted18.94%Today's Trading Volume1,499,248 sharesAverage Trading Volume2,418,683 sharesToday's Volume Vs. Average62% Short Selling Heron Therapeutics? Sign up to receive the latest short interest report for Heron Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHRTX Short Interest Over TimeHRTX Days to Cover Over TimeHRTX Percentage of Float Shorted Over Time Ad Golden CrestBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide Heron Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202428,810,000 shares $50.13 million -6.0%N/A15.7 $1.74 10/15/202430,640,000 shares $55.15 million -3.3%N/A14.9 $1.80 9/30/202431,700,000 shares $63.08 million -10.6%N/A14.4 $1.99 9/15/202435,440,000 shares $66.27 million -1.3%N/A14.9 $1.87 8/31/202435,920,000 shares $69.33 million -0.1%N/A15.5 $1.93 8/15/202435,960,000 shares $70.12 million +0.9%N/A14.9 $1.95 Get the Latest News and Ratings for HRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Heron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202435,630,000 shares $105.82 million -0.1%N/A14.9 $2.97 7/15/202435,660,000 shares $118.03 million +8.7%N/A14.7 $3.31 6/30/202432,820,000 shares $114.87 million +7.7%N/A14 $3.50 6/15/202430,470,000 shares $109.69 million +1.4%N/A14.5 $3.60 5/31/202430,040,000 shares $111.15 million -0.8%N/A12.3 $3.70 5/15/202430,270,000 shares $90.81 million +10.9%N/A12.6 $3.00 4/30/202427,290,000 shares $63.31 million +7.3%N/A11.6 $2.32 4/15/202425,430,000 shares $75.02 million -0.5%N/A9.8 $2.95 3/31/202425,550,000 shares $70.77 million +0.5%N/A8.8 $2.77 3/15/202425,430,000 shares $77.82 million +3.7%N/A8.4 $3.06 2/29/202424,530,000 shares $65.25 million -0.4%N/A8.8 $2.66 2/15/202424,620,000 shares $70.91 million +1.2%N/A8.4 $2.88 1/31/202424,330,000 shares $58.64 million +13.1%N/A6.6 $2.41 1/15/202421,520,000 shares $46.27 million +6.5%N/A6.5 $2.15 12/31/202320,210,000 shares $34.36 million -3.8%N/A6 $1.70 12/15/202321,000,000 shares $38.01 million -2.7%N/A6.8 $1.81 11/30/202321,580,000 shares $26.54 million +22.7%N/A7.4 $1.23 11/15/202317,590,000 shares $15.13 million -4.5%N/A6.4 $0.86 10/31/202318,410,000 shares $11.73 million -4.9%N/A9.1 $0.64 10/15/202319,360,000 shares $13.99 million -26.5%N/A8.9 $0.72 9/30/202326,330,000 shares $27.12 million +2.3%N/A12.8 $1.03 9/15/202325,750,000 shares $31.16 million +1.7%N/A13.4 $1.21 8/31/202325,320,000 shares $41.52 million -8.8%N/A12.7 $1.64 8/15/202327,760,000 shares $46.50 million +14.2%N/A13.2 $1.68 7/31/202324,310,000 shares $40.35 million +9.4%N/A10.4 $1.66 7/15/202322,220,000 shares $28.22 million -1.0%N/A10.1 $1.27 6/30/202322,440,000 shares $26.03 million -2.0%N/A9.7 $1.16 6/15/202322,890,000 shares $29.99 million -2.1%N/A8.9 $1.31 5/31/202323,380,000 shares $26.65 million +8.0%N/A9 $1.14 5/15/202321,650,000 shares $28.79 million -2.9%N/A8.8 $1.33 4/30/202322,300,000 shares $53.30 million -3.8%N/A10.8 $2.39 4/15/202323,190,000 shares $63.31 million +0.2%N/A10.8 $2.73 3/31/202323,150,000 shares $34.96 million +1.5%N/A10.9 $1.51 3/15/202322,800,000 shares $53.81 million -2.0%N/A12.7 $2.36Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 2/28/202323,270,000 shares $55.15 million -11.0%N/A10.2 $2.37 2/15/202326,140,000 shares $68.75 million -2.4%N/A11.2 $2.63 1/31/202326,790,000 shares $72.60 million -1.0%N/A10.5 $2.71 1/15/202327,070,000 shares $85.81 million +8.2%N/A10.7 $3.17 12/30/202225,030,000 shares $62.58 million -13.2%N/A9.7 $2.50 12/15/202228,840,000 shares $73.25 million +2.2%N/A10.8 $2.54 11/30/202228,220,000 shares $76.48 million -0.6%N/A10 $2.71 11/15/202228,400,000 shares $90.88 million -1.3%N/A10.1 $3.20 10/31/202228,770,000 shares $110.76 million -1.4%N/A9.3 $3.85 10/15/202229,180,000 shares $107.09 million -12.7%N/A9 $3.67 9/30/202233,420,000 shares $141.03 million +2.1%N/A10.1 $4.22 9/15/202232,720,000 shares $159.35 million +0.2%N/A9.7 $4.87 8/31/202232,650,000 shares $133.54 million -4.0%N/A10.8 $4.09 8/15/202234,000,000 shares $182.58 million -15.9%N/A11.2 $5.37 7/31/202240,430,000 shares $112.40 million +0.6%N/A14.3 $2.78 7/15/202240,180,000 shares $118.13 million +10.3%N/A14.9 $2.94 6/30/202236,440,000 shares $101.67 million -6.5%47.0%13.8 $2.79 6/15/202238,980,000 shares $99.40 million +5.5%50.3%15.5 $2.55 5/31/202236,960,000 shares $121.97 million -0.1%N/A14.6 $3.30 5/15/202236,980,000 shares $132.76 million -0.1%N/A14.4 $3.59 4/30/202237,010,000 shares $167.29 million -0.5%N/A15.7 $4.52 4/15/202237,200,000 shares $218.36 million -5.3%N/A16.2 $5.87 3/31/202239,280,000 shares $224.68 million +16.0%N/A17.1 $5.72 3/15/202233,850,000 shares $163.83 million -2.6%N/A15 $4.84 2/28/202234,750,000 shares $246.73 million -1.4%N/A15.2 $7.10 2/15/202235,240,000 shares $311.52 million +1.7%N/A16.9 $8.84 1/31/202234,640,000 shares $301.71 million -6.3%N/A16.5 $8.71 1/15/202236,960,000 shares $321.55 million +0.9%N/A0 $8.70 12/31/202136,650,000 shares $334.61 million +7.9%N/A18.9 $9.13 12/15/202133,970,000 shares $306.41 million +8.1%N/A17.6 $9.02 11/30/202131,430,000 shares $297.01 million +2.1%N/A18.8 $9.45 11/15/202130,790,000 shares $336.53 million +3.6%N/A21.4 $10.93 10/29/202129,730,000 shares $327.33 million +5.2%N/A21.4 $11.01 10/15/202128,270,000 shares $299.38 million +5.1%N/A21.4 $10.59 9/30/202126,900,000 shares $287.56 million +2.0%N/A20.2 $10.69 9/15/202126,370,000 shares $307.47 million -3.1%N/A21.3 $11.66 8/31/202127,220,000 shares $317.66 million +5.9%N/A21.3 $11.67 8/13/202125,710,000 shares $284.10 million +0.1%N/A17.3 $11.05 7/30/202125,690,000 shares $317.53 million +5.9%N/A14 $12.36 7/15/202124,250,000 shares $317.43 million +2.2%N/A13.9 $13.09 6/30/202123,720,000 shares $368.13 million -1.4%N/A13.8 $15.52 6/15/202124,050,000 shares $372.05 million +1.6%N/A14.5 $15.47 5/28/202123,680,000 shares $314.23 million +11.8%N/A14.5 $13.27 5/14/202121,180,000 shares $329.03 million +0.8%N/A14.3 $15.54 4/30/202121,010,000 shares $370.20 million -1.9%N/A20.4 $17.62 4/15/202121,410,000 shares $369.75 million +1.5%N/A21.2 $17.27 3/31/202121,100,000 shares $322.83 million +2.7%N/A20.9 $15.30 3/15/202120,550,000 shares $348.12 million +2.0%N/A19 $16.94 2/26/202120,150,000 shares $363.71 million +2.2%N/A19.4 $18.05 2/12/202119,710,000 shares $364.83 million +3.0%N/A19.1 $18.51Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 1/29/202119,140,000 shares $351.41 million +7.8%N/A17.9 $18.36 1/15/202117,760,000 shares $325.72 million +1.3%N/A17.2 $18.34 12/31/202017,530,000 shares $372.86 million -0.4%N/A18.8 $21.27 12/15/202017,600,000 shares $316.10 million -5.2%N/A19.8 $17.96 11/30/202018,560,000 shares $333.89 million +2.5%N/A23 $17.99 11/15/202018,100,000 shares $328.15 million +3.6%N/A23.2 $18.13 10/30/202017,480,000 shares $280.38 million +0.5%N/A24.2 $16.04 10/15/202017,390,000 shares $272.85 million +2.0%N/A23.5 $15.69 9/30/202017,050,000 shares $252.68 million +10.5%N/A20.4 $14.82 9/15/202015,430,000 shares $238.86 million +0.8%N/A12.2 $15.48 8/31/202015,310,000 shares $218.93 million -6.0%N/A11.6 $14.30 8/14/202016,280,000 shares $252.50 million +1.5%N/A12.2 $15.51 7/31/202016,040,000 shares $261.29 million -5.3%N/A11.5 $16.29 7/15/202016,930,000 shares $277.65 million -9.9%N/A11.8 $16.40 6/30/202018,790,000 shares $276.40 million +10.2%N/A13.4 $14.71 6/15/202017,050,000 shares $326.68 million +2.6%N/A15.8 $19.16 5/29/202016,620,000 shares $306.14 million -0.2%N/A13.5 $18.42 5/15/202016,650,000 shares $251.75 million -2.8%N/A12.7 $15.12 4/30/202017,120,000 shares $244.13 million +3.2%N/A13 $14.26 4/15/202016,590,000 shares $239.56 million -0.4%N/A12.7 $14.44 3/31/202016,650,000 shares $243.92 million -8.1%N/A12 $14.65 3/13/202018,109,400 shares $261.50 million -7.0%N/A11.9 $14.44 2/28/202019,480,000 shares $211.94 million +2.0%N/A16.4 $10.88 2/14/202019,090,000 shares $292.27 million +2.9%N/A17.2 $15.31 1/31/202018,560,000 shares $342.80 million +2.4%N/A16.9 $18.47 1/15/202018,120,000 shares $395.20 million -2.6%N/A16.8 $21.81 12/31/201918,600,000 shares $420.36 million +2.4%23.5%18.4 $22.60 HRTX Short Interest - Frequently Asked Questions What is Heron Therapeutics' current short interest? Short interest is the volume of Heron Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 28,810,000 shares of HRTX short. Learn More on Heron Therapeutics' current short interest. What is a good short interest ratio for Heron Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HRTX shares currently have a short interest ratio of 16.0. Learn More on Heron Therapeutics's short interest ratio. Is Heron Therapeutics' short interest increasing or decreasing? Heron Therapeutics saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 28,810,000 shares, a drop of 6.0% from the previous total of 30,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Heron Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Heron Therapeutics: Generation Bio Co. (3.40%), Mersana Therapeutics, Inc. (7.99%), Revance Therapeutics, Inc. (9.53%), Anavex Life Sciences Corp. (21.59%), Immunome, Inc. (21.37%), Entrada Therapeutics, Inc. (7.68%), Nuvation Bio Inc. (4.94%), ORIC Pharmaceuticals, Inc. (16.51%), Stoke Therapeutics, Inc. (12.65%), CorMedix Inc. (10.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Heron Therapeutics stock? Short selling HRTX is an investing strategy that aims to generate trading profit from Heron Therapeutics as its price is falling. HRTX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Heron Therapeutics? A short squeeze for Heron Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HRTX, which in turn drives the price of the stock up even further. How often is Heron Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HRTX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Generation Bio Short Squeeze Mersana Therapeutics Short Squeeze Revance Therapeutics Short Squeeze Anavex Life Sciences Short Squeeze Immunome Short Squeeze Entrada Therapeutics Short Squeeze Nuvation Bio Short Squeeze ORIC Pharmaceuticals Short Squeeze Stoke Therapeutics Short Squeeze CorMedix Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HRTX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
